FDA Panel Votes to Approve Vaccine for Children Ages 5-11
Final approval for the use of the Pfizer-BioNTech COVID-19 vaccine could come next week.
An FDA advisory panel Tuesday gave their stamp of approval for the use of Pfizer’s COVID-19 vaccine for children ages 5 to 11, According to the Washington Post, The FDA's advisory committee announced the decision after a study found that the benefits for children who receive inoculation far outweigh the potential risks of cardiac arrest symptoms.
Final approval must come from the FDA, and it is expected that the approval will come next week. Once they approve it, it will go to Director Wallensky for her approval because this, after all is the Federal Government.
Dr. Anthony Fauci on Sunday said that if approved, the vaccine could be available for the young age group sometime in the first two weeks of November.
“If all goes well, and we get the regulatory approval and the recommendation from the CDC, it’s entirely possible, if not very likely, that vaccines will be available for children from 5 to 11 within the first week or two of November,” Fauci said on ABC’s “This Week.”